Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Peritoneal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 5Mitomycin 4Hyperthermic Intraperitoneal Chemotherapy 4Fluorouracil 4Cisplatin 4Paclitaxel 3Doxorubicin 3Standard of Care 2Leucovorin 2Docetaxel 2Blood Specimen Collection 2Bevacizumab 2sodium thiosulfate 1relacorilant 1liposomal doxorubicin 1irinotecan sucrosofate 1dehydroftorafur 1X-Rays 1Topotecan 1Specimen Handling 1Practice Guidelines as Topic 1Platinum 1Pancreatectomy 1Pafolacianine 1Observation 1Mitozytrex 1Magnetic Resonance Spectroscopy 1Letrozole 1Laparoscopy 1LY-2157299 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Peritoneal Neoplasms × LY-2157299 × Clear all
NCT05700656 2024-07-22

Galunisertib Combined With Capecitabine in Advanced CRC With PM

The Netherlands Cancer Institute

Phase 1/2 Recruiting
31 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡